Sakar Healthcare Limited (SAKAR) - Net Assets

Latest as of March 2026: Rs3.24 Billion INR ≈ $35.09 Million USD

Based on the latest financial reports, Sakar Healthcare Limited (SAKAR) has net assets worth Rs3.24 Billion INR (≈ $35.09 Million USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Rs4.81 Billion ≈ $52.02 Million USD) and total liabilities (Rs1.57 Billion ≈ $16.93 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Sakar Healthcare Limited tangible equity quality to evaluate the tangible quality of the company's equity base.

Key Net Assets Metrics

Metric	Value
Current Net Assets	Rs3.24 Billion
% of Total Assets	67.45%
Annual Growth Rate	22.66%
5-Year Change	154.54%
10-Year Change	813.88%
Growth Volatility	22.6

Sakar Healthcare Limited - Net Assets Trend (2010–2026)

This chart illustrates how Sakar Healthcare Limited's net assets have evolved over time, based on quarterly financial data. See Sakar Healthcare Limited (SAKAR) defensive interval to measure how many days the company can operate on defensive assets alone.

Annual Net Assets for Sakar Healthcare Limited (2010–2026)

The table below shows the annual net assets of Sakar Healthcare Limited from 2010 to 2026. For live valuation and market cap data, see how much is Sakar Healthcare Limited worth.

Year	Net Assets	Change
2026-03-31	Rs3.24 Billion ≈ $35.09 Million	+13.65%
2025-03-31	Rs2.85 Billion ≈ $30.87 Million	+8.82%
2024-03-31	Rs2.62 Billion ≈ $28.37 Million	+51.33%
2023-03-31	Rs1.73 Billion ≈ $18.75 Million	+36.00%
2022-03-31	Rs1.27 Billion ≈ $13.78 Million	+29.47%
2021-03-31	Rs984.52 Million ≈ $10.65 Million	+21.07%
2020-03-31	Rs813.20 Million ≈ $8.79 Million	+13.41%
2019-03-31	Rs717.04 Million ≈ $7.75 Million	+39.25%
2018-03-31	Rs514.93 Million ≈ $5.57 Million	+45.04%
2017-03-31	Rs355.03 Million ≈ $3.84 Million	+85.08%
2016-03-31	Rs191.82 Million ≈ $2.07 Million	+29.37%
2015-03-31	Rs148.28 Million ≈ $1.60 Million	+6.90%
2014-03-31	Rs138.71 Million ≈ $1.50 Million	+14.46%
2013-03-31	Rs121.19 Million ≈ $1.31 Million	-11.92%
2012-03-31	Rs137.59 Million ≈ $1.49 Million	+3.65%
2011-03-31	Rs132.75 Million ≈ $1.44 Million	+7.47%
2010-03-31	Rs123.53 Million ≈ $1.34 Million	--

Equity Component Analysis

This analysis shows how different components contribute to Sakar Healthcare Limited's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have decreased by 100.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (March 2026)

Component	Amount	Percentage
Common Stock	Rs222.50 Million	6.86%
Other Components	Rs3.02 Billion	93.14%
Total Equity	Rs3.24 Billion	100.00%

Sakar Healthcare Limited Competitors by Market Cap

The table below lists competitors of Sakar Healthcare Limited ranked by their market capitalization.

Company	Market Cap
Li-FT Power Ltd. F:WS0	$188.94 Million
AVerMedia Technologies Inc TW:2417	$188.96 Million
Bien Yapi Urunleri Sanayi Turizm ve Ticaret A.S. IS:BIENY	$189.04 Million
Golden Ventures Leasehold Real Estate Investment Trust BK:GVREIT	$189.20 Million
Gansu Mogao Industrial Development Co Ltd SHG:600543	$188.90 Million
Kang Yong Electric Public Company Limited BK:KYE	$188.85 Million
Olimpo Real Estate SA MC:YORE	$188.72 Million
VS Industry Bhd KLSE:6963	$188.71 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Sakar Healthcare Limited's equity between the two most recent reporting periods.

Equity Growth Insights

From 2025 to 2026, total equity changed from 2,854,759,000 to 3,244,525,000, a change of 389,766,000 (13.7%).
Net income of 304,846,000 contributed positively to equity growth.
New share issuances of 86,400,000 increased equity.
Other comprehensive income decreased equity by 28,800,000.

Equity Change Factors (2025 to 2026)

Factor	Impact	Contribution
Net Income	Rs304.85 Million	+9.4%
Share Issuances	Rs86.40 Million	+2.66%
Other Comprehensive Income	Rs-28.80 Million	-0.89%
Other Changes	Rs27.32 Million	+0.84%
Total Change	Rs-	13.65%

Book Value vs Market Value Analysis

This analysis compares Sakar Healthcare Limited's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 5.46x
The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
The price-to-book ratio has decreased from 47.68x to 5.46x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2010-03-31	Rs16.69	Rs795.90	x
2011-03-31	Rs17.93	Rs795.90	x
2012-03-31	Rs17.20	Rs795.90	x
2013-03-31	Rs15.15	Rs795.90	x
2014-03-31	Rs17.34	Rs795.90	x
2015-03-31	Rs18.53	Rs795.90	x
2016-03-31	Rs23.98	Rs795.90	x
2017-03-31	Rs32.39	Rs795.90	x
2018-03-31	Rs34.42	Rs795.90	x
2019-03-31	Rs52.78	Rs795.90	x
2020-03-31	Rs54.35	Rs795.90	x
2021-03-31	Rs61.55	Rs795.90	x
2022-03-31	Rs84.41	Rs795.90	x
2023-03-31	Rs93.23	Rs795.90	x
2024-03-31	Rs127.81	Rs795.90	x
2025-03-31	Rs131.00	Rs795.90	x
2026-03-31	Rs145.81	Rs795.90	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Sakar Healthcare Limited utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): 9.40%
The company has moderate efficiency in generating returns from equity.
DuPont Analysis Breakdown:
• Net Profit Margin: 12.11%
• Asset Turnover: 0.52x
• Equity Multiplier: 1.48x
Recent ROE (9.40%) is above the historical average (9.09%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2010	6.61%	5.10%	0.36x	3.62x	Rs-4.19 Million
2011	5.18%	3.42%	0.41x	3.68x	Rs-6.39 Million
2012	5.60%	4.76%	0.32x	3.63x	Rs-6.05 Million
2013	11.92%	6.60%	0.44x	4.13x	Rs2.33 Million
2014	12.63%	5.90%	0.57x	3.77x	Rs3.65 Million
2015	12.39%	5.24%	0.70x	3.38x	Rs3.54 Million
2016	11.56%	5.38%	0.81x	2.66x	Rs3.00 Million
2017	9.52%	7.65%	0.63x	1.99x	Rs-1.72 Million
2018	7.41%	7.19%	0.65x	1.57x	Rs-13.35 Million
2019	9.78%	10.27%	0.69x	1.38x	Rs-1.59 Million
2020	11.83%	11.60%	0.72x	1.42x	Rs14.91 Million
2021	10.85%	11.28%	0.53x	1.81x	Rs8.37 Million
2022	11.96%	11.89%	0.48x	2.10x	Rs24.96 Million
2023	7.36%	9.57%	0.40x	1.94x	Rs-45.76 Million
2024	4.45%	7.57%	0.40x	1.48x	Rs-145.62 Million
2025	6.13%	9.86%	0.43x	1.45x	Rs-110.46 Million
2026	9.40%	12.11%	0.52x	1.48x	Rs-19.61 Million

Industry Comparison

This section compares Sakar Healthcare Limited's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.

Industry Context

Industry: Drug Manufacturers - Specialty & Generic
Average net assets among peers: $41,118,163,484
Average return on equity (ROE) among peers: 13.86%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
Sakar Healthcare Limited (SAKAR)	Rs3.24 Billion	6.61%	0.48x	$188.93 Million
Aarey Drugs & Pharmaceuticals Limited (AAREYDRUGS)	$366.97 Million	3.51%	2.41x	$25.11 Million
Aarti Drugs Limited (AARTIDRUGS)	$1.23 Billion	12.93%	2.27x	$365.36 Million
Aarti Pharmalabs Limited (AARTIPHARM)	$2.31 Million	-8.08%	0.08x	$645.54 Million
Abbott India Limited (ABBOTINDIA)	$2.31 Billion	29.62%	0.43x	$6.01 Billion
Ajanta Pharma Limited (AJANTPHARM)	$32.64 Billion	21.83%	0.24x	$4.15 Billion
Akums Drugs and Pharmaceutical (AKUMS)	$7.23 Billion	13.11%	3.52x	$996.26 Million
Alkem Laboratories Limited (ALKEM)	$75.58 Billion	20.97%	0.52x	$6.95 Billion
Amrutanjan Health Care Limited (AMRUTANJAN)	$1.09 Billion	18.92%	0.29x	$170.62 Million
Alembic Pharmaceuticals Limited (APLLTD)	$22.20 Billion	18.58%	0.77x	$1.59 Billion
Aurobindo Pharma Limited (AUROPHARMA)	$268.52 Billion	7.18%	0.49x	$8.98 Billion

About Sakar Healthcare Limited

NSE:SAKAR India Drug Manufacturers - Specialty & Generic

Market Cap

$188.93 Million

Rs17.47 Billion INR

Market Cap Rank

#16867 Global

#880 in India

Share Price

Rs795.90

Change (1 day)

-0.69%

52-Week Range

Rs317.10 - Rs844.15

All Time High

Rs844.15